Xanthomonas maltophilia: An emerging pathogen in patients with HIV disease

International Journal of STD and AIDS

Volumn 9, Issue 4, 1998, Pages 201-207

  Manfredi, Roberto ^a   Nanetti, Anna ^a   Ferri, Morena ^a   Chiodo, Francesco ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Antimicrobial susceptibility; Bacteraemia; HIV AIDS; Outcome; Risk factors; Treatment; Xanthomonas maltophilia

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIINFECTIVE AGENT; AZTREONAM; CEFALOTIN; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; IMIPENEM; MEZLOCILLIN; NETILMICIN; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TIMENTIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; CENTRAL VENOUS CATHETERIZATION; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; RISK FACTOR; SALMONELLOSIS; STENOTROPHOMONAS MALTOPHILIA; STEROID THERAPY;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-BACTERIAL AGENTS; BACTEREMIA; DRUG THERAPY, COMBINATION; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; XANTHOMONAS;

EID: 0031952643     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462981922043     Document Type: Article

References (55)

1. Elting LS, Khardori N, Bodey GP, Fainstain V. Nosocomial infection caused by Xanthomonas maltophilia. A case-control study of predisposing factors. Infect Contr Hosp Epidemiol 1990;11:134-8
2. Arpi M, Victor MA, Moller JK, et al. Changing etiology of bacteremia of patients with hematological malignancies in Denmark. Scand J Infect Dis 1994;26:157-62
3. Victor MA, Arpi M, Bruun B, Jonsson V, Hansen MM. Xanthomonas maltophilia bacteremia in immunocompromised hematological patients. Scand J Infect Dis 1994;26:163-70
4. Rispal P, Maugein J, Lasseur C, et al. Infections nosocomiales à Xanthomonas maltophilia. Une nouvelle menace. A propos de 30 observations. Rev Med Interne 1994;15:808-12
5. Spencer RC. The emergence of epidemic, multiple-antibiotic-resistant Stenotrophomonas (Xanthomonas) maltophilia and Burkholderia (Pseudomonas) cepacia. J Hosp Infect 1995;30(suppl):453-64
6. Papadakis KA, Vartivarian SE, Vassilaki ME, Anaissie EJ. Stenotrophomonas maltophilia: an unusual cause of biliary sepsis. Clin Infect Dis 1995;21:1032-4
7. Vartivarian SE, Papadakis KA, Anaissie EJ. Stenotrophomonas (Xanthomonas) maltophilia urinary tract infection. A disease that is usually severe and complicated. Arch Intern Med 1996;156:433-51
8. Chow AW, Wong J, Bartlett KH. Synergistic interactions of ciprofloxacin and extended-spectrum beta-lactams or aminoglycosides against multiple drug-resistant Pseudomonas maltophilia. Antimicrob Agents Chemother 1988;6:782-4
9. Vartivarian S, Anaissie E, Bodey G, Sprigg H, Rolston K. A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy. Antimicrob Agents Chemother 1994;38:624-7
10. Skoutelis AT, Murphy RL, MacDonell KB, VonRoenn JH, Sterkel CD, Phair JP. Indwelling central venous catheter infections in patients with acquired immunodeficiency syndrome. J Acquir Immune Defic Syndr 1990;3:335-42
11. Nelson MR, Shanson DC, Barter GJ, Hawkins DA, Gazzard BG. Pseudomonas septicaemia associated with HIV. AIDS 1991;5:761-3
12. Chen S, Stroh EM, Wald K, Jalkh A. Xanthomonas maltophilia endophthalmitis after implantation of sustained-release ganciclovir. Am J Ophthalmol 1992;114:772-3
13. Krumholz HM, Sande MA, Lo B. Community-acquired bacteremia in patients with acquired immunodeficiency syndrome: clinical presentation, bacteriology, and outcome. Am J Med 1989;86:776-9
14. Roilides E, Marshall D, Venzon D, Butler K, Husson R, Pizzo PA. Bacterial infection in human immunodeficiency virus type 1-infected children. The impact of central venous catheters and antiretroviral agents. Pediatr Infect Dis J 1991;10:813-19
15. Franzetti F, Cernuschi M, Esposito R, Moroni M. Pseudomonas infections in patients with AIDS and AIDS-related complex. J Intern Med 1992;231:437-43
16. Roilides E, Butler KM, Husson RN, Mueller BU, Lewis LL, Pizzo PA. Pseudomonas infections in children with human immunodeficiency virus infection. Pediatr Infect Dis J 1992;11:547-53
17. Soriano V, Valencia E, Alba A, Gonzalez Lahoz J. Endocarditis por Xanthomonas maltophilia en un paciente con SIDA. Med Clin Barc 1994;102:399
18. Fichtenbaum CJ, Dunagan WC, Powderly WG. Bacteremia in hospitalized patients infected with the human immunodeficiency virus: a case-control study of risk factors and outcome. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:51-7
19. Bernard E, Carles M, Pradier C, Ozouf N, Dellamonica P. Septicémies communautaires et nosocomiales chez le patient infecté par le virus de l'immunodéficience humaine. Presse Med 1996;25:746-50
20. Sitges M, Mito O, Pedrol E. Neumonia intrahospitalaria por Xanthomonas maltophilia y SIDA. Arch Bronconeumol 1996;32:259-60
21. Flores G, Stavola JJ, Noel GJ. Bacteremia due to Pseudomonas aeruginosa in children with AIDS. Clin Infect Dis 1993;16:706-8
22. Bernstein LJ, Krieger BZ, Novick B, Sicklick MJ, Rubinstein A. Bacterial infections in the acquired immunodeficiency syndrome of children. Pediatr Infect Dis J 1985;4:472-5
23. Gilks CF, Brindle RJ, Otieno LS, et al. Life-threatening bacteraemia in HIV-1 seropositive adults admitted to hospital in Nairobi, Kenya. Lancet 1990;336:545-9
24. Andiman WA, Mezger J, Shapiro E. Invasive bacterial infections in children born to women infected with human immunodeficiency virus type 1. J Pediatr 1994;124:846-52
25. Berger BJ, Hussain F, Roistacher K. Bacterial infections in HIV-infected patients. Infect Dis Clin North Am 1994;8:449-65
26. Ruiz Contreras J, Ramos JT, Hernandez Sampelayo T, Gurbindo MD, De José M, Garcia de Miguel MJ, Cilleruelo MJ, Mellado MJ and the Madrid HIV Pediatric Infection Collaborative Study Group. Sepsis in children with human immunodeficiency virus infection. Pediatr Infect Dis J 1995;14:522-6
27. Jacobson MA, Gellermann H, Chambers H. Staphylococcus aureus bacteremia and recurrent staphylococcal infection in patients with acquired immunodeficiency syndrome and AIDS-related complex. Am J Med 1988;85:172-6
28. Kielhofner M, Atmar RL, Hamill RJ, Musher DM. Life-threatening Pseudomonas aeruginosa infection in patients with human immunodeficiency virus infection. Clin Infect Dis 1992;14:403-11
29. Fichtenbaum CJ, Woeltje KF, Powderly WG. Serious Pseudomonas aeruginosa infections in patients infected with human immunodeficiency virus: a case-control study. Clin Infect Dis 1994;19:417-22
30. Hirschtick RE, Glassroth J, Jordan MC, Wilcosky TC, Wallace JM, Kvale PA, Markowitz N, Rosen MJ, Mangura BT, Hopewell PC, and the Pulmonary Complications of HIV Infection Study Group. Bacterial pneumonia in persons infected with the human immunodeficiency virus. N Engl J Med 1995;333:845-51
31. Shepp DH, Tang ITL, Ramundo MB, Kaplan MH. Serious Pseudomonas aeruginosa infection in AIDS. J Acquir Immune Defic Syndr 1994;7:823-31
32. Dropulic LK, Leslie JM, Eldred LJ, Zenilman J, Sears CL. Clinical manifestations and risk factors of Pseudomonas aeruginosa infection in patients with AIDS. J Infect Dis 1995;171:930-7
33. Hambleton J, Aragon T, Modin G, Northfelt DW, Sande MA. Outcome for hospitalized patients with fever and neutropenia who are infected with the human immunodeficiency virus. Clin Infect Dis 1995;20:363-71
34. Whimbey E, Gold JWM, Polski B, et al. Bacteremia and fungemia in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1986;104:511-14
35. Schuster MG, Norris AH. Community-acquired Pseudomonas aeruginosa pneumonia in patients with HIV infection. AIDS 1994;8:1437-41
36. Miller RF, Foley NM, Kessel D, Jeffrey AA. Community acquired lobar pneumonia in patients with HIV infection and AIDS. Thorax 1994;49:367-8
37. Tumbarello M, Tacconelli E, Caponera S, Cauda R, Ortona L. The impact of bacteraemia on HIV infection. Nine years experience in a large Italian university hospital. J Infect 1995;31:123-31
38. Meyer CN, Skinhoj P, Prag J. Bacteremia in HIV-positive and AIDS patients: incidence, species distribution, risk-factors, outcome, and influence of long-term prophylactic antibiotic treatment. Scand J Infect Dis 1994;26:635-42
39. Fish DN, Danziger LH. Neglected pathogens: bacterial infections in persons with human immunodeficiency virus infection. A review of the literature. Pharmacotherapy 1993;13:415-39, 543-63
40. Burack JH, Hahn JA, Saint-Maurice D, Jacobson MA. Microbiology of community-acquired bacterial pneumonia in patients with and at risk for human immunodeficiency virus type 1 infections. Implications for rational empiric antibiotic therapy. Arch Intern Med 1994;154:2589-96
41. Raviglione MC, Battan R, Pablos Mendez A, Aceves Casillas P, Mullen MP, Taranta A. Infections associated with Hickman catheters in patients with acquired immunodeficiency syndrome. Am J Med 1989;86:780-6
42. Goetz AM, Squier C, Wagener MM, Muder RR. Nosocomial infections in the human immunodeficiency virus-infected patient: a two-year survey. Am J Infect Control 1994;22:334-9
43. Schlamm HT, Yancovitz SR. Haemophilus influenzae pneumonia in young adults with AIDS, ARC, or at risk for AIDS. Am J Med 1989;86:11-14
44. Sperber SJ, Schleupner CJ. Salmonellosis during infection with human immunodeficiency virus. Rev Infect Dis 1987;9:925-34
45. Hoepelman ALM, Van Buren M, Van den Broeck J, Borleffs JCC. Bacteriuria in men infected with HIV-1 is related to their immune status (CD4+ cell count). AIDS 1992;6: 179-84
46. Vugia DJ, Kiehlbauch JA, Yeboue K, et al. Pathogens and predictors of fatal septicemia associated with human immunodeficiency virus infection in Ivory Coast, West Africa. J Infect Dis 1993;168:564-70
47. Manfredi R, Nanetti A, Ferri M, et al. Clinical and microbiological features of non-typhoid salmonellosis in patients with HIV infection. Mediterranean J Infect Parasitic Dis 1994;9:165-70
48. Witt DJ, Craven DE, McCabe WR. Bacterial infections in adult patients with the acquired immune deficiency syndrome (AIDS) and AIDS-related complex. Am J Med 1987;82:900-6
49. Polski B, Gold JWM, Whimbey E, et al. Bacterial pneumonia in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1986;104:38-41
50. Berenguer J, Solera J, Diaz MD, Moreno S, Lopez-Herce JA, Bouza E. Listeriosis in patients infected with human immunodeficiency virus. Rev Infect Dis 1991;13:115-19
51. Rodriguez Barradas MC, Musher DM, Hamill RJ, Dowell M, Bagwell JT, Sander CV. Unusual manifestations of pneumococcal infechon in human immunodeficiency virus-infected individuals: the past revisited. Rev Infect Dis 1992;14:192-9
52. Janoff EN, Breiman RF, Daley CL, Hopewell PC. Pneumococcal disease during HIV infection: epidemiological, clinical, and immunologic perspectives. Ann Intern Med 1992;117:314-24
53. Manfredi R, Nanetti A, Ferri M, Coronado OV, Mastroianni A, Chiodo F. Profile and trend of antimicrobial resistance of non-opportunistic bacterial pathogens isolated from patients with HIV infection. J Antimicrob Chemother 1996;38:910-13
54. Baron AD, Hollander H. Pseudomonas aeruginosa bronchopulmonary infection in late human immunodeficiency virus disease. Am Rev Respir Dis 1993;148:992-6
55. Ruga E, Giaquinto C, Cozzani S, et al. The use of antibiotics in the treatment and prevention of infection in HIV-infected children. Acta Paediatr 1994;(suppl 400):70-2